GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shield Therapeutics PLC (FRA:1JS) » Definitions » Other Liabilities for Insurance Companies

Shield Therapeutics (FRA:1JS) Other Liabilities for Insurance Companies


View and export this data going back to 2016. Start your Free Trial

What is Shield Therapeutics Other Liabilities for Insurance Companies?

Other Liabilities for Insurance Companies only applies to insurance companies.


Shield Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
Northern Design Centre, Baltic Business Quarter, Gateshead Quays, Newcastle, GBR, NE8 3DF
Shield Therapeutics PLC is a commercial stage specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals that address areas of high unmet medical need. The company's operating segments are based on key products including PT20 and Feraccru, involves development and commercialisation of the Group's main Feraccru product, and PT20 is used in treating hyperphosphatemia, which is in its last stage of completion. The company generates maximum revenue from the Feraccru segment.